Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hPOD neonatal hypoglycaemia prevention trial
ACTRN12614001263684Phase 3Completed
- Sponsor
- The University of Auckland
- Start
- Jan 2015
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in Neonatal hypoglycemia comparing 40% dextrose gel with Placebo gel (2 arms). Primary endpoint: Admission to NICU/SCBU for more than 4 hours. Started Jan 2015; status: completed.
02
Drugs
dextrose
03
Conditions
Neonatal hypoglycemia
Beyond the preview
Go deeper on ACTRN12614001263684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614001263684.